Spend enough time in bodybuilding circles and peptides start to sound like a cheat code. More muscle. Faster recovery. Easier fat loss.

The reality is more complicated than this.

The problem isn't that people are interested in peptides. It's that the word has become a catch-all for several completely different compounds, and the evidence behind them is far from equal. A licensed weight-loss medicine used in the NHS is not the same as a mystery vial bought from a supplement website. And something being popular on bodybuilding forums doesn't make it proven, safe, or legal. But it doesn't automatically make it useless either.

Once you separate the categories, the picture gets much clearer.

Contents

• Why are bodybuilders so interested in peptides?

• What actually is a peptide?

• The three categories you need to know

  • Weight loss peptides (e.g. Wegovy, Mounjaro)

  • Growth hormone secretagogues (e.g. CJC-1295, MK-677)

  • Recovery peptides (e.g. BPC-157, TB-500)

• What about sleep, libido, and anti-ageing?

Only have a minute?

'Peptides' are not one thing. In bodybuilding and hormone circles, the word usually covers three very different groups:

1. Weight-loss peptides — such as semaglutide and tirzepatide, which are regulated medicines with strong clinical evidence in the right patients.
2. Growth hormone secretagogues — such as CJC-1295 and ipamorelin, which boost growth hormone levels. But it's not exactly clear how this translates into muscle-building effects.
3. Recovery peptides — such as BPC-157, which is widely discussed for tendon and tissue healing. The animal data looks promising, but human trials are sparse.

Some peptide medicines have strong evidence behind them. However, many of the compounds doing the rounds online do not. At least, not yet. So before asking whether peptides work, you need to ask: which one, for what goal, and what does the evidence actually show?

Why are bodybuilders so interested in peptides?

The appeal comes down to their supposed benefits: more muscle, easier fat loss, faster recovery, better sleep, and the idea that peptides offer a shortcut that sidesteps the risks of anabolic steroids.

Some of that interest has been driven by real medical advances. Drugs like semaglutide have impressive evidence for weight loss. But once a few compounds in a category prove clinically useful, it becomes very easy for the rest of the category to borrow that credibility, even when the evidence lags significantly behind.

What actually is a peptide?

A peptide is a short chain of amino acids. It's smaller than a protein but made of the same building blocks. Your body makes peptides naturally, and many of them act as chemical messengers to signal hunger, trigger hormone release, repair tissues, as well as dozens of other processes.

That's why peptides appear as treatments across different areas of medicine, from diabetes care to fertility treatment to hormone optimisation.

It's also why the word on its own tells you almost nothing. Saying 'I'm taking peptides' is a bit like saying 'I'm taking medication.' It's important to know which one, what it's for, and what the evidence is saying.

The three peptide categories you need to know

1. Weight-loss peptides (with strong clinical evidence)

This is where semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) sit. These are GLP-1 receptor agonists, a class of medicines that mimic gut hormones involved in appetite regulation. In simple terms, they help the brain receive the signal that you're full, reducing appetite and calorie intake over time.

They are not fat burners in the gym-supplement sense. They are regulated medicines, available on prescription, and recommended by NICE for adults with obesity alongside lifestyle changes.

The evidence is substantial. A 2024 meta-analysis found that semaglutide 2.4 mg produced meaningful and sustained weight loss [1], and tirzepatide studies show comparable results [2]. Side effects, mainly nausea and gastrointestinal symptoms, are real and worth discussing with a clinician.

What about combining weight-loss peptides and TRT?

For men with low testosterone, there's an added consideration. Obesity and low testosterone are closely linked. Excess body fat drives the conversion of testosterone to oestrogen, suppressing the body's own production. Weight loss through GLP-1 treatment can help, but for men with clinically confirmed hypogonadism, it may not be enough to restore testosterone to an optimal range on its own. Combining a GLP-1 programme with TRT addresses both sides by supporting fat loss while maintaining testosterone levels. Find out more about GLP-1 and TRT at Leger.

2. Growth hormone secretagogues

This is where most people in performance and bodybuilding circles end up.

Compounds like CJC-1295, ipamorelin, sermorelin, GHRP-6, and ibutamoren (MK-677) are designed to increase the body's own production of growth hormone (GH) and IGF-1. The first part works: these peptides do raise GH and IGF-1 levels [4,5]. That's not in dispute.

Where it gets more complicated is translating higher hormone levels into real-world outcomes.

Even studies giving people growth hormone directly — not peptides that stimulate it, but GH itself — show modest results in healthy adults. Increases in lean mass appear, but strength improvements are inconsistent, and some of that lean mass gain is thought to reflect fluid retention rather than new muscle tissue [6,7]. This matters because if exogenous GH underdelivers in healthy people, secretagogues that raise endogenous GH face a similar ceiling.

Part of the reason is that muscle growth isn't primarily driven by circulating GH or IGF-1. It's a local process, heavily dependent on training and signalling within the muscle itself. Higher numbers on a blood test don't automatically mean more hypertrophy.

It's also worth being honest about why the evidence is lacking. Natural peptides are unpatentable compounds. There's no commercial incentive for a pharmaceutical company to fund the large, long-term trials that would settle the questions. The evidence gap is partly a funding gap, and 'limited human evidence' is not the same as 'doesn't work.' It just means we can't make confident claims in either direction and it's difficult to comment on their safety profile [8].

What about recovery?

This is probably the strongest case for growth hormone, and it's not unreasonable. GH plays a role in protein turnover and collagen synthesis, and human studies have shown it increases collagen synthesis in tendons and muscle tissue [9]. In theory, it could support structural repair. High-quality evidence that this translates into meaningfully faster recovery from training is still limited, but the mechanism is plausible.

In older adults and those with genuine GH deficiency, the picture is clearer. Raising GH can improve body composition and physical function in this group [5,10].

What about combining them with TRT?

One point worth addressing directly is men on TRT who consider adding a GH secretagogue to their protocol. The logic is reasonable. TRT handles testosterone, so why not optimise GH alongside it?

The practical problem is that stacking compounds multiplies the complexity. TRT already produces meaningful improvements in body composition, recovery, and energy, particularly in the early months of a well-managed protocol. Adding a GH secretagogue makes it genuinely difficult to know what's driving what. Under proper medical supervision with regular monitoring, that's a navigable question. Without it, you're managing two sets of unknowns simultaneously with no reliable baseline.

For men on TRT, the most productive starting point is ensuring the current protocol is properly optimised before introducing additional variables.

3. Recovery peptides — BPC-157 and similar

BPC-157 and TB-500 are the most talked-about compounds in this space, typically marketed for healing tendons, ligaments, joints, and muscle tissue.

The animal data is genuinely interesting. BPC-157 has shown consistent effects on tissue repair across multiple animal models, with proposed mechanisms including new blood vessel formation and modulation of growth factor signalling [11].

The human evidence, however, is currently very limited. A 2025 systematic review found no meaningful clinical safety data and only very low-level human studies, including a small retrospective report in knee pain [12]. The authors flagged real risks from unregulated manufacturing, contamination, and unknown dosing. The gap between 'interesting in animals' and 'proven in humans' is still significant.

Is BPC-157 legal in the UK?

BPC-157 is not an approved medicine and is generally considered unregulated or illegal to sell for human consumption. For anyone competing in tested sport, it's named on WADA's 2026 prohibited list under non-approved substances [13]. The anti-doping risk is real. TB-500 (a synthetic derivative of thymosin beta-4) shares the same core limitations: very limited human clinical data and WADA prohibited status.

What about sleep, libido, and anti-ageing?

Beyond muscle and fat loss, peptides are also marketed for sleep quality, libido, cognitive function, and anti-ageing. The evidence base here is even more limited.

Ibutamoren (MK-677) is sometimes cited for sleep, on the basis that GH is released primarily during deep sleep and that boosting GH secretion may improve sleep quality. There is some limited data in older adults suggesting modest effects. Effect sizes are small, studies are few, and long-term safety in healthy adults isn't well characterised.

For libido and cognitive claims, the evidence is largely anecdotal. These are not compelling reasons on their own to use unlicensed compounds. If you're experiencing issues in those areas, the more productive question is usually whether your testosterone, thyroid function, and metabolic health have been properly assessed first. This is where the Leger team can help.

The bottom line

The honest answer on peptides isn't a simple one.

Some peptide medicines, particularly GLP-1 weight-loss drugs, have genuine, well-evidenced clinical uses in the right patients. Growth hormone secretagogues have plausible biology and a real evidence gap that partly reflects a lack of commercial funding rather than proof of failure. Recovery peptides like BPC-157 have promising animal data and very limited human evidence, alongside genuine regulatory risk.

At Leger, we focus on what actually works, not what's trending on forums. If you're considering fat loss treatment, we offer a proper clinical assessment to see whether a GLP-1 programme is right for you. And if it's not, we'll tell you. We don't offer unregulated peptides. But if you're on TRT and want to make sure it's properly optimised, or you're exploring medically supervised weight management, that's exactly what we're here for. Get in touch, and we can discuss the next best steps with you.

FAQs

Do peptides build muscle?

The licensed peptides with the strongest evidence (GLP-1 weight-loss drugs) aren't muscle-building compounds. For growth hormone secretagogues, the biology is plausible but the human evidence for meaningful muscle gain in healthy adults remains limited. Recovery peptides like BPC-157 have interesting animal data, but adequate human trials are lacking. The peptides people most often take hoping to build muscle don't yet have the evidence to make confident claims.

Do peptides help with fat loss?

Yes, but only the right ones. Semaglutide and tirzepatide have strong clinical evidence for meaningful fat loss in eligible patients. NICE recommends both within specific criteria, alongside lifestyle changes. For the wider category of online 'fat-burning peptides', a plausible mechanism affecting appetite or metabolism is not the same as proven, safe, durable fat loss in real people. That evidence doesn't yet exist for most compounds marketed this way.

Are peptides steroids?

No. Peptides and anabolic steroids are different things, and WADA treats them as separate categories on the prohibited list. But 'not a steroid' is a low bar. A compound can still be poorly studied, banned in sport, or purchased from an unregulated source. It's worth keeping that in mind.

Are peptides legal in the UK?

It depends on the peptide. Licensed medicines like semaglutide and tirzepatide can be legally prescribed for specific purposes, though both appear on WADA's 2026 Monitoring Programme, meaning their use in competition is under active surveillance [14]. For unlicensed compounds sold as 'research peptides', the MHRA is clear that selling unauthorised medicines is illegal, and products bought from unregistered online pharmacies carry real risks around quality, sterility, and dosing [15]. For athletes, WADA's 2026 prohibited list names peptide hormones and related substances as a prohibited class, including BPC-157 specifically [13].

References

1. Qin W, Yang J, Deng C, Ruan Q, Duan K. Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial. Diabetes Obes Metab. 2024;26: 911–923. doi:10.1111/dom.15386
2. Tan B, Pan X-H, Chew HSJ, Goh RSJ, Lin C, Anand VV, et al. Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis. Int J Obes. 2023;47: 677–685. doi:10.1038/s41366-023-01321-5
3. Eisa N, Barood O. Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Diabetes Obes Metab. 2026. doi:10.1111/dom.70666
4. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne J-P, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91: 799–805. doi:10.1210/jc.2005-1536
5. Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE, Clasey JL, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149: 601–611. doi:10.7326/0003-4819-149-9-200811040-00003
6. Hermansen K, Bengtsen M, Kjær M, Vestergaard P, Jørgensen JOL. Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials. Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc. 2017;34: 38–44. doi:10.1016/j.ghir.2017.05.005
7. Meinhardt U, Nelson AE, Hansen JL, Birzniece V, Clifford D, Leung K-C, et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med. 2010;152: 568–577. doi:10.7326/0003-4819-152-9-201005040-00007
8. Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018;6: 45–53. doi:10.1016/j.sxmr.2017.02.004
9. Doessing S, Heinemeier KM, Holm L, Mackey AL, Schjerling P, Rennie M, et al. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol. 2010;588: 341–351. doi:10.1113/jphysiol.2009.179325
10. White HK, Petrie CD, Landschulz W, MacLean D, Taylor A, Lyles K, et al. Effects of an Oral Growth Hormone Secretagogue in Older Adults. J Clin Endocrinol Metab. 2009;94: 1198–1206. doi:10.1210/jc.2008-0632
11. Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal®. 2025;21: 485–495. doi:10.1177/15563316251355551
12. Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025; 15563316251355551. doi:10.1177/15563316251355551
13. WADA. World Anti-Doping Code International Standard Prohibited List 2026. 2026. Available: WADA 2026 Prohibited List (PDF).
14. WADA. The 2026 Monitoring Program. 2026.
15. Medicines information - NHS. [cited 27 Mar 2026]. Available: https://www.nhs.uk/tests-and-treatments/medicines-information/